Effects of Extracorporeal Shock Wave Therapy After Flexor Tendon Injury
Condition(s) studied
Investigational drug(s) / intervention(s)
Ekstracorporeal Shock Wave Therapy: Radial ESWT with 2 bar pressure, 10 Hz frequency, and 2000 pulses will be applied to the flexor tendon scar tissue in a total of 4 sessions, once a week, using a sweeping method with gel applied between the patient's skin and the probe.
Study summary
In this study aims to investigate the effects of extracorporeal shock wave therapy, applied to the intervention group in addition to the rehabilitation program applied to the control and intervention groups, on range of motion, pain, grip strength, and dexterity after hand flexor tendon injury.
Eligibility
Primary outcome measure(s)
- Visual Analog Scale — Evaluation will be performed before treatment, on the day treatment ends, and one month after treatment.
For VAS assessment, patients are informed about the meaning of the numbers placed on a 10 cm line from 0 to 10. It is explained that no pain is worth 0 points, moderate pain is worth 5 points, and the most severe pain felt is worth 10 points. Based on these explanations, the patient is asked to mark the pain on the 10 cm line. The distance between the marked point and the starting point is measured with a ruler to determine the pain intensity. - Range of Motion — Evaluation will be performed before treatment, on the day treatment ends, and one month after treatment.
Range of motion (ROM) is one of the most frequently used outcome variables after tendon injuries in the hand. ROM measurement in the hand is performed using a finger goniometer. In active ROM assessment for the fingers, the patient is asked to make a fist for flexion and extend the finger straight; that is, the measurement is performed in a compound manner. In this study, the Modified Strickland calculation will be used for fingers 2-5. Active distal interphalangeal (DIF) and proximal interphalangeal (PIF) joint flexion are added together, and the active extension loss is subtracted. 175° is considered ideal and compared to 175°. The results are; 75°-100° is considered excellent, 50°-74° good, 25°-49° average, and 0°-24° poor.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ankara Bilkent City Hospital | Ankara | Turkey (Türkiye) | Recruiting |
More Kirsehir Ahi Evran Universitesi trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07320807 on ClinicalTrials.gov ↗ ← All trials in Turkey